Spoken Alpha
TWST
Twist Bioscience Corp
Overview
Twist Bioscience designs and manufactures synthetic DNA using a proprietary silicon-based platform that miniaturizes chemical reactions to produce oligonucleotides and genes at scale.
Twist Bioscience Corp is a Healthcare company operating in Diagnostics & Research with a $5.22B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 2, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-02-027 Q&A exchanges
- Q4 FY2025Earnings2025-11-1414 Q&A exchanges
- Q3 FY2025Earnings2025-08-0411 Q&A exchanges
- Q2 FY2025Earnings2025-05-0511 Q&A exchanges
- Q1 FY2025Earnings2025-02-0312 Q&A exchanges
- Q4 FY2024Earnings2024-11-1814 Q&A exchanges
- Q3 FY2024Earnings2024-08-0213 Q&A exchanges
- Q2 FY2024Earnings2024-05-0213 Q&A exchanges
- Q1 FY2024Earnings2024-02-0226 Q&A exchanges
- Q4 FY2023Earnings2023-11-1717 Q&A exchanges
- Q3 FY2023Earnings2023-08-0418 Q&A exchanges
- Q2 FY2023Earnings2023-05-0528 Q&A exchanges
- Q1 FY2023Earnings2023-02-0316 Q&A exchanges
- Q4 FY2022Earnings2022-11-1831 Q&A exchanges
- Q3 FY2022Earnings2022-08-0513 Q&A exchanges
- Q2 FY2022Earnings2022-05-0515 Q&A exchanges
- Q1 FY2022Earnings2022-02-0418 Q&A exchanges
- Q4 FY2021Earnings2021-11-2222 Q&A exchanges
- Q3 FY2021Earnings2021-08-0624 Q&A exchanges
- Q2 FY2021Earnings2021-05-0712 Q&A exchanges
- Q1 FY2021Earnings2021-02-0519 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-02EPS— vs $-0.49—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-02 | — | $-0.49 | — | — | — | — | EODHD |
Source: EODHD. TWST reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks TWST's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.98 | $1.72 | +15.4% | -2.0% | -1.7% |
| Q4 FY2026 | $1.97 | $1.80 | +9.5% | +3.3% | +5.6% |
| Q3 FY2026 | $2.12 | $1.80 | +17.9% | -6.3% | -6.9% |
| Q2 FY2026 | $2.10 | $1.82 | +15.6% | -4.1% | -4.9% |
| Q1 FY2025 | $2.07 | $1.85 | +12.0% | +4.3% | +6.0% |
| Q4 FY2025 | $2.14 | $1.75 | +22.1% | -2.8% | -4.2% |
| Q3 FY2025 | $1.91 | $1.76 | +8.7% | -1.8% | -0.7% |
| Q2 FY2025 | $2.28 | $1.87 | +21.8% | -3.8% | -6.7% |
| Q1 FY2024 | $2.17 | $1.96 | +10.9% | -2.6% | -2.8% |
| Q4 FY2024 | $2.04 | $1.89 | +7.9% | +2.6% | +1.0% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Emily M LeproustCEO4 mo16 callsCurrentSample
CEO since 2026 • 1/2 beats (50%) • guidance suspended Q3 FY2026
- Adam LaponisCFO4 mo9 callsCurrentSample
CFO since 2026 • 2/2 beats (100%) • last guidance raise Q1 FY2026
- Patrick John FinnCOO4 mo1 callCurrentSample
COO since 2026 • 1/2 beats (50%) • last call held guidance Q1 FY2026
- Robert F WernerChief Accounting Officer4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 2/2 beats (100%) • guidance suspended Q2 FY2026
- Paula GreenSVP of Human Resources4 mono recorded callsCurrentSample
DIVISION_HEAD since 2026 • 1/2 beats (50%) • guidance suspended Q1 FY2026
- Dennis ChoSee Remarks4 mono recorded callsCurrentSample
OTHER since 2026 • 2/2 beats (100%) • guidance suspended Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TWST.
$ curl https://api.spokenalpha.com/v1/companies/TWSTFAQ
Frequently asked about TWST
Where can I find Twist Bioscience Corp's (TWST) earnings call transcripts?
Spoken Alpha indexes TWST's earnings call transcripts at https://spokenalpha.com/companies/TWST. Each call links to attributed speakers and parsed analyst Q&A. Twist Bioscience Corp's own investor relations page is at https://investors.twistbioscience.com/.
When was Twist Bioscience Corp's most recent earnings call?
Twist Bioscience Corp (TWST) held its most recent earnings call on 2026-02-02, covering fiscal Q1 2026.
What sector is TWST in?
Twist Bioscience Corp (TWST) operates in the Healthcare sector (Diagnostics & Research industry).